ATE323154T1 - Verfahren zur isolierung eines proteins - Google Patents

Verfahren zur isolierung eines proteins

Info

Publication number
ATE323154T1
ATE323154T1 AT01947593T AT01947593T ATE323154T1 AT E323154 T1 ATE323154 T1 AT E323154T1 AT 01947593 T AT01947593 T AT 01947593T AT 01947593 T AT01947593 T AT 01947593T AT E323154 T1 ATE323154 T1 AT E323154T1
Authority
AT
Austria
Prior art keywords
protein
interest
solid support
complex medium
isolation
Prior art date
Application number
AT01947593T
Other languages
English (en)
Inventor
Patrick Berna
Christelle Clement
Original Assignee
Warner Lambert Co
Meristem Therapeutics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co, Meristem Therapeutics filed Critical Warner Lambert Co
Application granted granted Critical
Publication of ATE323154T1 publication Critical patent/ATE323154T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C12N9/20—Triglyceride splitting, e.g. by means of lipase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Nutrition Science (AREA)
  • Surgery (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
AT01947593T 2000-06-23 2001-06-22 Verfahren zur isolierung eines proteins ATE323154T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0008118A FR2810667B1 (fr) 2000-06-23 2000-06-23 Procede d'isolement et de purification d'une proteine, et proteine obtenue

Publications (1)

Publication Number Publication Date
ATE323154T1 true ATE323154T1 (de) 2006-04-15

Family

ID=8851639

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01947593T ATE323154T1 (de) 2000-06-23 2001-06-22 Verfahren zur isolierung eines proteins

Country Status (8)

Country Link
US (1) US20040102615A1 (de)
EP (1) EP1297116B1 (de)
JP (1) JP2004505615A (de)
AT (1) ATE323154T1 (de)
AU (1) AU6924501A (de)
DE (1) DE60118739T2 (de)
FR (1) FR2810667B1 (de)
WO (1) WO2001098473A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1403274A1 (de) * 2002-09-30 2004-03-31 Meristem Therapeutics Verfahren zur Reinigung von rekombinanten Proteinen aus komplexen Medien sowie die auf diese Weise erhaltenen gereinigten Proteine
WO2005005460A1 (en) * 2003-07-10 2005-01-20 Novo Nordisk A/S Method of washing and concentrating protein precipitates by means of a centrifugal field and fluidization conditions
JP4149504B2 (ja) * 2006-12-07 2008-09-10 松下電器産業株式会社 フェリチンを基板上に二次元配列させる方法
CN101687906A (zh) 2007-05-16 2010-03-31 马里兰大学，大学城 回收叶蛋白的新方法
SG10201500036WA (en) 2010-04-30 2015-02-27 Asahi Kasei Pharma Corp Highly-purified soluble thrombomodulin and method for producing same
US10421795B2 (en) 2012-12-17 2019-09-24 Merck Sharp & Dohme Corp. Process for purifying insulin and analogues thereof
CN103013951B (zh) * 2012-12-27 2014-03-26 江南大学 一种提取纯化小麦胚芽脂肪酶的方法
GB201318840D0 (en) * 2013-10-24 2013-12-11 Univ Leeds Method and device for protein preparation
CN108350165B (zh) * 2015-09-04 2021-08-17 巴斯夫欧洲公司 用于纯化粗聚醚多元醇的方法
JP7037811B2 (ja) * 2018-03-19 2022-03-17 地方独立行政法人鳥取県産業技術センター スフェロイド形成促進剤の精製方法
CN112500471B (zh) * 2020-12-22 2022-09-27 中美华世通生物医药科技(武汉)股份有限公司 一种制备高澄清度蛋白琥珀酸铁的方法
CN112827210A (zh) * 2020-12-24 2021-05-25 四川德博尔制药有限公司 一种澄清胰脏提取液的制备方法
CN119951164B (zh) * 2024-12-23 2025-10-10 陕西科技大学 一种食用菌活性成分的级联提取工艺

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL182575C (nl) * 1974-06-10 Gb Fermentation Ind Inc Werkwijze voor de afscheiding van een lipolytisch enzym uit het fermentatiekweekmedium van mucor miehei, alsmede het gebruik van deze werkwijze voor de bereiding van lipase-vrije rennine.
DE3342870A1 (de) * 1983-11-26 1985-06-05 Boehringer Mannheim Gmbh, 6800 Mannheim Digitalis-antikoerper, verfahren zu ihrer herstellung und ihre verwendung zur therapie von digitalis-intoxikationen
US5169936A (en) * 1989-04-14 1992-12-08 Biogen, Inc. Protein purification on immobilized metal affinity resins effected by elution using a weak ligand
EP0574050A1 (de) * 1992-05-19 1993-12-15 Gist-Brocades N.V. Trennung und Reinigung von Fermentationsprodukt in grossen Massstab
FR2699179B1 (fr) * 1992-12-16 1995-01-06 Jouveinal Inst Rech Acides nucléiques codant pour la lipase gastrique de chien et dérivés polypeptidiques, leur utilisation pour la production de ces polypeptides, et compositions pharmaceutiques à base de ces derniers.
FR2733249B1 (fr) * 1995-04-20 1997-06-06 Biocem Lipase gastrique de chien recombinante et polypeptides derives produits par les plantes, leurs procedes d'obtention et leurs utilisations
AU5996996A (en) * 1995-06-02 1996-12-18 Novo Nordisk A/S Al/fe-treatment of a protein solution, followed by membrane concentration

Also Published As

Publication number Publication date
WO2001098473A2 (fr) 2001-12-27
US20040102615A1 (en) 2004-05-27
WO2001098473A3 (fr) 2002-05-02
DE60118739D1 (de) 2006-05-24
AU6924501A (en) 2002-01-02
DE60118739T2 (de) 2006-11-09
EP1297116A2 (de) 2003-04-02
FR2810667A1 (fr) 2001-12-28
JP2004505615A (ja) 2004-02-26
FR2810667B1 (fr) 2004-09-03
EP1297116B1 (de) 2006-04-12

Similar Documents

Publication Publication Date Title
ATE323154T1 (de) Verfahren zur isolierung eines proteins
WO2004055164A3 (en) System and method for stabilizing antibodies with histidine
NO20014534L (no) Fremgangsmåte ved adskillelse av proteiner
DE69807650D1 (de) Entfernung von bindemittel
WO2007130535A3 (en) Novel protein fusion/tag technology
ATE408017T1 (de) Verfahren zur rna und protein synthese
ATE300295T1 (de) Verwendung von baclofen zur behandlung von alkoholismus
ATE340191T1 (de) Methoden zur isolation von proteinaseinhibitor proteinen von kartoffeln knollen
ATE335004T1 (de) Verfahren zur reinigung von prpres aus einem biologischen muster und dessen verwendung
ATE312596T1 (de) Verfahren zur herstellung wasserdispergierbarer trockenpulver von in wasser schwer l slichen verbindungen
BR0015823A (pt) Método para purificar proteìnas
ATE412890T1 (de) Verfahren zur tensid-quantifizierung eines proteinpräparates
DE60003057D1 (de) Verfahren zur extraktion mit einem überkritischen fluid
DE60106482D1 (de) Verfahren zur Herstellung von 3-Oxo-4-azasteroiden
DE50103488D1 (de) Verfahren zur oxidation eines alkens
ATE326225T1 (de) Xanthin-glycol-derivate zur behandlung des reizdarmsyndroms
ATE323101T1 (de) Verfahren zur trocknung von proteinkristallen
ATE201045T1 (de) Verfahren zur verhinderung der zersetzung des proteins c
ATE124706T1 (de) Verfahren zur isolierung von basalmembranproteinen aus menschlichen und tierischen geweben.
ATE468032T1 (de) Verfahren zur verringerung von herbheit
ATE175240T1 (de) Verfahren zur ausfällung von natürlichen avermectinen, sowie fermentationsverfahren zur herstellung derselben
DE60104866D1 (de) Aminoalkenylbenzoyl-benzofurane oder benzothiophene, verfahren zur ihrer herstellung und sie enthaltende zubereitungen
ATE474454T1 (de) Verfahren zur einbringung von molekülen in zellen
DE60123959D1 (de) Verfahren zur extraktion und verbesserung der verdaubarkeit von palmaria palmata proteinen
MXPA02010182A (es) Metodos de uso de penicilaminas para el tratamiento de condiciones que resultan del dano en el adn.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties